ORAL ABX464 QD IS EFFICACIOUS AND SAFE DURING PHASE 2B INDUCTION AND MAINTENANCE TREATMENT OF ULCERATIVE COLITIS PATIENTS

Severine Vermeire  ¹     Paul GINESTE  ²     Herbert Tilg  ³     Silvio Danese  ⁴     Radoslaw Kempinski  ⁵     Zsolt Tulassay  ⁶     Josianne Nitcheu  ⁶     Sophie Biguenet  ⁶     Hartmut Ehrlich  ⁶     Jean-Marc Steens  ⁶     William Sandborn  ⁷     Bruce E. Sands  ^8    
1 KU Leuven, Leuven, Belgium
² Abivax, Paris, France
³ Medical University Innsbruck, Innsbruck, Austria
⁴ Gastroenterology and Endoscopy and University Vita-Salute, San Raffaele, Milano, Italy
⁵ Wroclaw Medical University, Wroclaw, Poland
⁶ Semmelweis University, Budapest, Hungary
⁷ University of California - San Diego, San Diego, United States
⁸ Mont Sinai School of Medicine, New York, United States

Topic
IBD

Session
Late-breaking Abstracts III: Clinical trials in IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)